EO 14398 IDIQ: chemistry, manufacturing and controls and related services for development of drug substances (trnd 1)
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N95026D00005
- Awardee
-
TCG Inc. UEI DRUNBSXBERD5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances Solicitation · 75N95024R00094 · Posted Oct 9, 2024
- Last date to order 5% complete
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 11 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute on Drug Abuse awarded a multiple-award indefinite-delivery contract to TCG Inc. on August 1, 2026, with a contract ceiling of $49,713,679 and ultimate completion date of May 14, 2031. This is an unrestricted procurement with no set-aside designation.
The IDIQ supports Chemistry, Manufacturing, and Controls (CMC) and related services for the development of drug substances in preclinical and Investigational New Drug (IND)-enabling studies. The solicitation, posted October 9, 2024 with proposals due December 3, 2024, encompassed three technical areas: small molecules, peptides, and biopharmaceuticals. Offerors could propose on one, two, or all three areas. Evaluation criteria addressed technical approach, personnel qualifications, facilities, quality management, and organizational experience.
The period of performance runs from September 1, 2025 through May 14, 2031. The contract carries a $1,000 minimum guarantee per IDIQ awardee. Work is performed in the United States.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N95026D00005?
75N95026D00005 was awarded to TCG Inc. by National Institute on Drug Abuse (National Institutes of Health) on August 1, 2026.
Who can order from contract 75N95026D00005?
75N95026D00005 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N95026D00005 competed?
The extent of competition for 75N95026D00005 was full and open competition. The government received 11 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV